Suppr超能文献

成人神经源性压力性尿失禁手术治疗的疗效与安全性:一项系统评价

Efficacy and Safety of Surgical Treatments for Neurogenic Stress Urinary Incontinence in Adults: A Systematic Review.

作者信息

Musco Stefania, Ecclestone Hazel, 't Hoen Lisette, Blok Bertil F M, Padilla-Fernández Barbara, Del Popolo Giulio, Groen Jan, Pannek Jürgen, Kessler Thomas M, Karsenty Gilles, Phé Véronique, Sartori Andrea M, Castro-Diaz David, Rizwan Hamid

机构信息

Department of Neuro-Urology, Careggi University Hospital, Florence, Italy.

Department of Urology, Taranaki District Health Board, New Plymouth, New Zealand.

出版信息

Eur Urol Focus. 2022 Jul;8(4):1090-1102. doi: 10.1016/j.euf.2021.08.007. Epub 2021 Sep 9.

Abstract

CONTEXT

Controversy still exists regarding the balance of benefits and harms for the different surgical options for neurogenic stress urinary incontinence (N-SUI).

OBJECTIVE

To identify which surgical option for N-SUI offers the highest cure rate and best safety without compromising urinary tract function and bladder management.

EVIDENCE ACQUISITION

A systematic review was performed under the auspices of the European Association of Urology Guidelines Office and the European Association of Urology Neuro-Urology Guidelines Panel according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement.

EVIDENCE SYNTHESIS

A total of 32 studies were included. Overall, 852 neurourological patients were surgically treated for N-SUI. The treatment offered most often (13/32 studies) was an artificial urinary sphincter (AUS; 49%, 416/852) and was associated with a need for reintervention in one-third of patients. More than 200 surgical revisions were described. Overall, 146/852 patients (17%) received concomitant bladder augmentation, mainly during placement of an AUS (42%, 62/146) or autologous sling (34% of women and 14% of men). Following pubovaginal sling placement, dryness was achieved in 83% of cases. A significant improvement in N-SUI was observed in 87% (82/94) of women following placement of a synthetic midurethral sling. Efficacy after insertion of an adjustable continence therapy device (ACT 40%, proACT 60%) was reported for 38/128 cases (30%). The cure rate for bulking agents was 35% (9/25) according to 2/32 studies, mainly among men (90%). The risk of bias was highly relevant. Baseline and postoperative cystometry were missing in 13 and 28 studies, respectively.

CONCLUSIONS

The evidence is mainly reported in retrospective studies. More than one intervention is often required to achieve continence because of coexisting neurogenic detrusor overactivity, low compliance, or the onset of complications in the medium and long term. Urodynamic data are needed to better clarify the success of N-SUI treatment with the different techniques.

PATIENT SUMMARY

Our review shows that insertion of an artificial urinary sphincter for urinary incontinence is effective but is highly associated with a need for repeat surgery. Other surgical options may have lower continence rates or a risk of requiring intermittent catheterization, which patients should be informed about before deciding on surgery for their incontinence.

摘要

背景

关于神经源性压力性尿失禁(N-SUI)不同手术选择的利弊平衡仍存在争议。

目的

确定哪种N-SUI手术选择能在不影响尿路功能和膀胱管理的情况下提供最高治愈率和最佳安全性。

证据获取

在欧洲泌尿外科学会指南办公室和欧洲泌尿外科学会神经泌尿学指南小组的主持下,根据系统评价和Meta分析的首选报告项目(PRISMA)声明进行了一项系统评价。

证据综合

共纳入32项研究。总体而言,852例神经泌尿外科患者接受了N-SUI手术治疗。最常提供的治疗方法(13/32项研究)是人工尿道括约肌(AUS;49%,416/852),三分之一的患者需要再次干预。描述了200多次手术翻修。总体而言,146/852例患者(17%)接受了同期膀胱扩大术,主要在放置AUS期间(42%,62/146)或自体吊带时(女性为34%,男性为14%)。耻骨后阴道吊带放置后,83%的病例实现了干燥。在放置合成尿道中段吊带后,87%(82/94)的女性N-SUI有显著改善。38/128例(30%)报告了插入可调节控尿治疗装置(ACT 40%,proACT 60%)后的疗效。根据2/32项研究,填充剂的治愈率为35%(9/25),主要见于男性(90%)。偏倚风险高度相关。13项和28项研究分别缺失基线和术后膀胱测压数据。

结论

证据主要来自回顾性研究。由于存在神经源性逼尿肌过度活动、顺应性低或中长期并发症的发生,通常需要不止一种干预措施才能实现控尿。需要尿动力学数据来更好地阐明不同技术治疗N-SUI的成功率。

患者总结

我们的综述表明,插入人工尿道括约肌治疗尿失禁是有效的,但与再次手术的需求高度相关。其他手术选择可能控尿率较低或有需要间歇性导尿的风险,在决定手术治疗尿失禁之前,应告知患者这些情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验